Every parliamentary written question tabled by Jodie Gosling this session, with the full answer and department. See how every department answers, or back to the MP page.
Showing 1–20 of 61 · this parliament
What the referral rate to hospital for female urinary incontinence treatment is for (a) the total population and (b) women from minority-ethnic backgrounds.
The data held on referrals to gynaecology services is not broken down by the reason of referral. This means it is not possible to identify referrals specifically for female urinary incontinence, either for the total population or for women from minority e...
What plans he has to improve referral rates for female urinary incontinence for women from minority-ethnic backgrounds.
The data held on referrals to gynaecology services is not broken down by the reason of referral. This means it is not possible to identify referrals specifically for female urinary incontinence, either for the total population or for women from minority e...
What steps he is taking to improve data collection and reporting of rates of treatment in women with urinary continence from minority-ethnic backgrounds.
The data held on referrals to gynaecology services is not broken down by the reason of referral. This means it is not possible to identify referrals specifically for female urinary incontinence, either for the total population or for women from minority e...
What assessment he has made of trends in the level of referral rates for female urinary incontinence for women from minority-ethnic backgrounds.
The data held on referrals to gynaecology services is not broken down by the reason of referral. This means it is not possible to identify referrals specifically for female urinary incontinence, either for the total population or for women from minority e...
Whether (a) physiotherapists, (b) occupational therapists, (c) nurses, (d) pharmacists, and (e) other healthcare professionals who have been eligible to issue fit notes since July 2022 will be issuing f
All healthcare professionals currently eligible to issue fit notes will continue to be able to do so. The Government is not bringing forward any changes to fit note legislation as part of the fit note reform pilots. The four fit note pilots will test a vo...
With reference to the NHS's document entitled Neighbourhood health centre guidance for regions and integrated care boards published on 16 April 2026, whether physiotherapists are included in the co
Neighbourhood health centres (NHCs) will bring together general practice (GP) with a mix of community, local authority, adult social care, and civil society services, allowing staff to deliver more coordinated and effective care for better patient outcome...
What recent steps his Department has taken to rectify poor quality works undertaken as part of the Energy Company Obligation 4 scheme.
We are offering an audit to all households that received external wall insulation (EWI) measures under ECO4 and GBIS schemes. Since this became fully operational in January, over 9,000 properties have been contacted, with over 3,000 audits completed. The ...
What steps his Department plans to take to retain the chief allied health professions officer role following the abolition of NHS England.
The proposed abolition of NHS England and associated transfer and modification of functions is subject to legislation and the will of Parliament. We will be engaging with partners inside and outside the organisations as the process to design the future De...
What proportion of senior NHS leadership roles are held by Allied Health Professionals; and what steps he is taking to increase that proportion.
The Department and NHS England do not currently hold a comprehensive central dataset on the proportion of all senior NHS Board-level roles held by Allied Health Professionals (AHPs).NHS England is actively seeking to increase representation from a broader...
Food and Rural Affairs, what assessment she has made of the potential impact of burial sites on downstream water quality during heavy rainfall.
Defra recognises that poorly located or managed burial sites can, in some circumstances, pose a risk to water quality, particularly during periods of heavy rainfall. At the same time, we understand that burial grounds are deeply important places for famil...
If his Department will update Schedule 17 of the Human Medicines Regulations 2012 to allow for use of adrenaline nasal sprays.
Following the approval of an adrenaline nasal spray by the Medicines and Healthcare products Regulatory Agency (MHRA) in July 2025, the Government is considering whether any amendments to Schedule 17 of the Human Medicines Regulations 2012 are appropriate...
Whether his Department has considered exempting information on how to use adrenaline devices from restrictions only allowing medical professionals to access information about prescription medicines
Following the approval of an adrenaline nasal spray by the Medicines and Healthcare products Regulatory Agency (MHRA) in July 2025, the Government is considering whether any amendments to Schedule 17 of the Human Medicines Regulations 2012 are appropriate...
Whether his Department has considered the potential merits of legislating to allow for community access to adrenaline.
Following the approval of an adrenaline nasal spray by the Medicines and Healthcare products Regulatory Agency (MHRA) in July 2025, the Government is considering whether any amendments to Schedule 17 of the Human Medicines Regulations 2012 are appropriate...
Commonwealth and Development Affairs, what steps her Department is taking with international partners to help tackle alleged human rights violations against members of the Bahá'í community in Iran, including repo
I refer the Hon Member to the answer provided on 19 May in response to Question 611.
What assessment he has made of the adequacy of current entry requirements for the armed forces reserve; and whether his Department plans to review entry requirements for the armed forces reserves.
The Ministry of Defence (MOD) continually assesses the entry requirements for Reserve recruitment and is actively streamlining joining processes, along with many other aspects of the Reserves, to ensure they support national resilience. This Government ha...
Whether he has made an assessment of the potential merits of introducing a permanent exemption to Jury service for people suffering from lifelong or degenerative conditions.
The Government has not made a specific assessment of introducing a permanent exemption for people with lifelong or degenerative conditions. Jury service is an important civic duty, and the Government is committed to ensuring that disability is never a barrier to serving.People with these conditions who feel unable to undertake jury service may apply to be excused, with each application considered carefully on a case-by-case basis.Where a person wishes to serve, His Majesty’s Courts and Tribunals Service will make reasonable adjustments to accommodate their needs whenever possible, so they can participate fully at no personal cost.
What the planned timeline is for publishing the next iteration of the taxonomy being developed as part of the ongoing reforms to Drug Tariff Part IX.
The final draft, version 1.2, of the Part IX Drug Tariff (Med Tech in the community) Wave 1 categorisation was developed in collaboration with an Expert Reference Group and updated in line with stakeholder feedback over four iterations. The final version was published in October 2025 and can be found on the NHS Business Services Authority Website at the following link:https://www.nhsbsa.nhs.uk/manufacturers-and-suppliers/drug-tariff-part-ix-informationThe Department is currently recruiting Independent Assessment Panels (IAPs) for Wave 1 and has agreed to ask them to review late feedback received from a company on the eye drops category. This is due to take place in February 2026 and will not require further input from industry as it has already been circulated for comment by them.The Department has also offered to review Drug Tariff Committee feedback regarding the categorisation of medical devices that fall into waves 2 to 4.The categorisation for waves 2 and 3 is currently being reviewed, and the Department expects to share the updated versions in early 2026 well in advance of the projected launch of waves 2 and 3 in 2027 and 2028 respectively. There are no confirmed plans for reviewing wave 4 at this time. The earliest launch would be in January 2029. All dates are subject to the outcome of the review of wave one.The Department recognises that the categorisation is not stagnant and may need further amendments as medical devices continue to evolve and the IAPs are stood up. Companies can suggest further amendments when they apply to Part IX of the Drug Tariff or through the Drug Tariff Committee.
What assessment he has made of the potential impact on community preparedness for anaphylaxis following new MHRA-approved adrenaline delivery formats with different usability and stability characteristics.
Officials at the Department, in discussion with the Medicines and Healthcare products Regulatory Agency, are in the early stages of considering if potential amendments to Schedule 17 of the Human Medicines Regulations (HMRs) 2012 are required to reflect the availability of new adrenaline delivery technologies.No specific assessment has been made of the potential impact on community preparedness for anaphylaxis. However, should amendments to the HMRs be required, then the Government will conduct a public consultation to ensure that the views of stakeholders are carefully considered, prior to any changes being made.If changes are made to the HMRs, all relevant guidance will be updated to reflect this change.
What discussions he has had with the Medicines and Healthcare Products Regulatory Agency on ensuring that regulations governing community access to emergency adrenaline remain aligned with innovation in (a) device design and (b) stability.
Officials at the Department, in discussion with the Medicines and Healthcare products Regulatory Agency, are in the early stages of considering if potential amendments to Schedule 17 of the Human Medicines Regulations (HMRs) 2012 are required to reflect the availability of new adrenaline delivery technologies.No specific assessment has been made of the potential impact on community preparedness for anaphylaxis. However, should amendments to the HMRs be required, then the Government will conduct a public consultation to ensure that the views of stakeholders are carefully considered, prior to any changes being made.If changes are made to the HMRs, all relevant guidance will be updated to reflect this change.
Whether his Department plans to review its guidance entitled Using emergency adrenaline auto-injectors in schools, published 20 September 2017, to reflect advances in authorised adrenaline delivery technologies.
Officials at the Department, in discussion with the Medicines and Healthcare products Regulatory Agency, are in the early stages of considering if potential amendments to Schedule 17 of the Human Medicines Regulations (HMRs) 2012 are required to reflect the availability of new adrenaline delivery technologies.No specific assessment has been made of the potential impact on community preparedness for anaphylaxis. However, should amendments to the HMRs be required, then the Government will conduct a public consultation to ensure that the views of stakeholders are carefully considered, prior to any changes being made.If changes are made to the HMRs, all relevant guidance will be updated to reflect this change.